C07C211/63

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):

##STR00001##

RESIST COMPOSITION AND PATTERNING PROCESS
20230021453 · 2023-01-26 · ·

A resist composition is provided comprising a base polymer and a quencher comprising a salt compound consisting of a cyclic ammonium cation and a 1,1,1,3,3,3-hexafluoro-2-propoxide anion having a trifluoromethyl, hydrocarbylcarbonyl or hydrocarbyloxycarbonyl group bonded thereto. The resist composition has a high sensitivity and forms a pattern with improved LWR or CDU, independent of whether it is of positive or negative tone.

RESIST COMPOSITION AND PATTERNING PROCESS
20230021453 · 2023-01-26 · ·

A resist composition is provided comprising a base polymer and a quencher comprising a salt compound consisting of a cyclic ammonium cation and a 1,1,1,3,3,3-hexafluoro-2-propoxide anion having a trifluoromethyl, hydrocarbylcarbonyl or hydrocarbyloxycarbonyl group bonded thereto. The resist composition has a high sensitivity and forms a pattern with improved LWR or CDU, independent of whether it is of positive or negative tone.

SHORT CONJUGATED OLIGOELECTROLYTESAND ANTIBIOTICS

Disclosed herein are combinations that include one or more conjugated oligoelectrolyte compounds, or pharmaceutically acceptable salts, hydrates, or solvates thereof, and one or more antibiotics. Combination of one or more conjugated oligoelectrolyte compounds and one or more antibiotics can potentiate the activity of the one or more antibiotics. Also disclosed are methods treating, reducing the severity of and/or slowing the progression of a bacterial infection, such as Gram-positive and Gram-negative bacteria, using a combination described herein.

Therapeutic agents and methods

The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.

Therapeutic agents and methods

The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.

CURING CATALYST USED FOR CURING OF POLYMER, MOISTURE CURABLE COMPOSITION,AND METHOD FOR PRODUCING CURED PRODUCT
20220411579 · 2022-12-29 · ·

When considering the prior art, the objective of the present invention is to provide a curing catalyst which is highly safe and has a curing rate suitable for practical use. According to the present invention, provided is a curing catalyst [B] which is used for curing a polymer [A] having a reactive hydrolyzable silicon-containing group, the curing catalyst [B] containing a metal alkoxide [B1] and an ammonium hydroxide [B2], wherein: the metal alkoxide [B1] includes one or both of a titanium compound [B1a] represented by chemical formula (1) and another metal alkoxide [B1b]; the another metal alkoxide [B1b] is an alkoxide of a metal other than titanium; and the ammonium hydroxide [B2] is represented by chemical formula (2).

CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED ARTICLE
20220410135 · 2022-12-29 · ·

The purpose of the present invention is to provide a curing catalyst that is highly stable and has a practical curing speed. The present invention provides a curing catalyst [B] used for curing a polymer [A] that has a reactive hydrolyzable silicon-containing group. The curing catalyst [B] contains the reaction products of a metal alkoxide [B1] and an ammonium hydroxide [B2]. The metal alkoxide [B1] includes one or both of a titanium compound [B1a] that is represented by chemical formula (1), and another metal alkoxide [B1b]. The other metal alkoxide [B1b] is an alkoxide of a metal other than titanium, and the ammonium hydroxide [B2] is represented by chemical formula (2).

SEPARATION OF RARE EARTH METALS
20230059863 · 2023-02-23 ·

A method for extracting a rare earth metal from a mixture of one or more rare earth metals, said method comprising contacting an acidic solution of the rare earth metal with a composition which comprises an ionic liquid to form an aqueous phase and a non-aqueous phase into which the rare earth metal has been selectively extracted.

METHOD FOR PRODUCING HALOGEN OXYACID SOLUTION

A method for producing halogen oxyacid, which includes a step of continuously supplying and mixing an organic alkali solution and a halogen and continuously collecting a reaction solution containing halogen oxyacid, and an production apparatus of halogen oxyacid, which includes a reactor, a means of supplying an organic alkali solution to the reactor, a means of supplying a halogen to the reactor, and a means of collecting a reaction solution for taking out the reaction solution from the reactor, in which the organic alkali solution and the halogen are continuously supplied by the means of supplying an organic alkali solution and the means of supplying a halogen, respectively, to the reactor so as to be mixed therein such that a solution containing halogen oxyacid is generated as a reaction solution, and the reaction solution is continuously collected by the means of collecting a reaction solution are provided.